Corporate strategic investment in digital health at all-time high

Corporate, or "strategic," investors are busy making digital health investments in smaller companies as they seek to fortify their presence in that important space. So far 2014 boasts about 70 deals worth $800 million, easily exceeding last year's total. Deal volume is nearly double that of 2012. Since 2010 strategic players have made 210 deals totaling $2.34 billion. Qualcomm Ventures is the largest strategic investor, followed by Merck Global Health Innovation fund, BlueCross BlueShield Venture Partners and and Google Ventures. Other strategics in digital health: Intel ($INTC), Johnson & Johnson ($JNJ), Dignity Health, Kaiser Permanente, Reed Elsevier and General Electric ($GE). More

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.